Leap Therapeutics Inc. (LPTX)
NASDAQ: LPTX
· Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM
6.87% (1D)
| Bid | 0.41 |
| Market Cap | 17.26M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -69.17M |
| EPS (ttm) | -1.67 |
| PE Ratio (ttm) | -0.25 |
| Forward PE | -0.75 |
| Analyst | Hold |
| Ask | 0.43 |
| Volume | 344,286 |
| Avg. Volume (20D) | 2,148,239 |
| Open | 0.39 |
| Previous Close | 0.39 |
| Day's Range | 0.37 - 0.42 |
| 52-Week Range | 0.22 - 4.79 |
| Beta | -0.22 |
About LPTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LPTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LPTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+16.88%
Leap Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
4 months ago
-12.06%
Leap Therapeutics shares are trading lower after HC Wainwright & Co downgraded the stock from Buy to Neutral.
